- Home
- CRDL vs AMPX Comparison
CRDL vs AMPX Comparison
Compare CRDL & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- AMPX
- Stock Information
- Founded
- CRDL 2017
- AMPX 2008
- Country
- CRDL Canada
- AMPX United States
- Employees
- CRDL N/A
- AMPX N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- AMPX Industrial Machinery/Components
- Sector
- CRDL Health Care
- AMPX Miscellaneous
- Exchange
- CRDL Nasdaq
- AMPX Nasdaq
- Market Cap
- CRDL 142.5M
- AMPX 154.4M
- IPO Year
- CRDL N/A
- AMPX N/A
- Fundamental
- Price
- CRDL $1.58
- AMPX $1.97
- Analyst Decision
- CRDL Strong Buy
- AMPX Strong Buy
- Analyst Count
- CRDL 3
- AMPX 7
- Target Price
- CRDL $9.00
- AMPX $8.17
- AVG Volume (30 Days)
- CRDL 421.9K
- AMPX 2.8M
- Earning Date
- CRDL 11-14-2024
- AMPX 11-07-2024
- Dividend Yield
- CRDL N/A
- AMPX N/A
- EPS Growth
- CRDL N/A
- AMPX N/A
- EPS
- CRDL N/A
- AMPX N/A
- Revenue
- CRDL N/A
- AMPX $17,480,000.00
- Revenue This Year
- CRDL N/A
- AMPX $65.92
- Revenue Next Year
- CRDL N/A
- AMPX $327.46
- P/E Ratio
- CRDL N/A
- AMPX N/A
- Revenue Growth
- CRDL N/A
- AMPX 196.22
- 52 Week Low
- CRDL $0.79
- AMPX $0.61
- 52 Week High
- CRDL $3.12
- AMPX $6.02
- Technical
- Relative Strength Index (RSI)
- CRDL 30.69
- AMPX 57.13
- Support Level
- CRDL $1.83
- AMPX $1.82
- Resistance Level
- CRDL $1.92
- AMPX $2.13
- Average True Range (ATR)
- CRDL 0.15
- AMPX 0.31
- MACD
- CRDL -0.04
- AMPX 0.00
- Stochastic Oscillator
- CRDL 12.00
- AMPX 50.97
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.